Digital therapists get stressed too, study finds
And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...
FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss
FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...
The cost of GLP-1s needs to come way down for benefits to be worth it, study says
In this photo illustration, the injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April ...
Healio12h
Societies take stand against off-brand GLP-1s over safety concerns
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
OPKO and Entera partner to develop obesity pill
(Reuters) -OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other ...
Fierce Biotech14h
Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic
The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...